Related Experiment Video
Updated: May 17, 2026

Habituation and Prepulse Inhibition of Acoustic Startle in Rodents
Published on: September 1, 2011
Aripiprazole reverses paliperidone-induced hyperprolactinemia
Nieves Basterreche1, Mercedes Zumárraga, Aurora Arrue
1Short Stay Unit, Hospital de Zamudio, Red de Salud Mental de Bizkaia, 48170 Zamudio, Bizkaia, Spain. nieves.basterrecheizaguirre@osakidetza.net
Hyperprolactinemia, a side effect of antipsychotics, can be reversed. Adding aripiprazole to paliperidone treatment effectively resolved this issue in a patient, avoiding dose reduction or antipsychotic switching.
Area of Science:
- Psychiatry
- Endocrinology
- Pharmacology
Background:
- Hyperprolactinemia is a frequent adverse effect of antipsychotic medications.
- Current management strategies involve dose reduction or switching antipsychotics, risking patient decompensation.
Observation:
- A female patient experienced hyperprolactinemia during paliperidone treatment.
- The patient was treated with a combination of paliperidone and aripiprazole (5 mg/day).
Findings:
- Combined treatment with aripiprazole (5 mg/day) successfully reversed paliperidone-induced hyperprolactinemia.
- The normalization of prolactin levels occurred within four weeks of initiating combined therapy.
Implications:
- Aripiprazole augmentation may be a viable strategy for managing antipsychotic-induced hyperprolactinemia.
- This approach offers an alternative to dose reduction or antipsychotic switching, potentially preserving treatment efficacy.
Related Concept Videos
Mania and Antimanic Drugs: Overview
Psychosis: Goals of Pharmacotherapy
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Psychosis and Antipsychotic Drugs: Overview
Antipsychotic Drugs: Typical and Atypical Agents
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...